-
1
-
-
84984777129
-
Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene
-
G.A. Jansen, R. Ofman, S. Ferdinandusse, L. Ijlst, A.O. Muijsers, O.H. Skjeldal, O. Stokke, C. Jakobs, G.T. Besley, J.E. Wraith, and R.J. Wanders Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene Nat. Genet. 17 1997 190 193
-
(1997)
Nat. Genet.
, vol.17
, pp. 190-193
-
-
Jansen, G.A.1
Ofman, R.2
Ferdinandusse, S.3
Ijlst, L.4
Muijsers, A.O.5
Skjeldal, O.H.6
Stokke, O.7
Jakobs, C.8
Besley, G.T.9
Wraith, J.E.10
Wanders, R.J.11
-
2
-
-
84984767118
-
Identification of PAHX, a Refsum disease gene
-
S.J. Mihalik, J.C. Morrell, D. Kim, K.A. Sacksteder, P.A. Watkins, and S.J. Gould Identification of PAHX, a Refsum disease gene Nat. Genet. 17 1997 185 189
-
(1997)
Nat. Genet.
, vol.17
, pp. 185-189
-
-
Mihalik, S.J.1
Morrell, J.C.2
Kim, D.3
Sacksteder, K.A.4
Watkins, P.A.5
Gould, S.J.6
-
3
-
-
0030745425
-
Phytanoyl-coenzyme a hydroxylase deficiency-the enzyme defect in Refsum's disease
-
G.A. Jansen, R.J. Wanders, P.A. Watkins, and S.J. Mihalik Phytanoyl-coenzyme A hydroxylase deficiency-the enzyme defect in Refsum's disease N. Engl. J. Med. 337 1997 133 134
-
(1997)
N. Engl. J. Med.
, vol.337
, pp. 133-134
-
-
Jansen, G.A.1
Wanders, R.J.2
Watkins, P.A.3
Mihalik, S.J.4
-
4
-
-
0037318856
-
Identification of PEX7 as the second gene involved in Refsum disease
-
D.M. van den Brink, P. Brites, J. Haasjes, A.S. Wierzbicki, J. Mitchell, M. Lambert-Hamill, J. de Belleroche, G.A. Jansen, H.R. Waterham, and R.J. Wanders Identification of PEX7 as the second gene involved in Refsum disease Am. J. Hum. Genet. 72 2003 471 477
-
(2003)
Am. J. Hum. Genet.
, vol.72
, pp. 471-477
-
-
Van Den Brink, D.M.1
Brites, P.2
Haasjes, J.3
Wierzbicki, A.S.4
Mitchell, J.5
Lambert-Hamill, M.6
De Belleroche, J.7
Jansen, G.A.8
Waterham, H.R.9
Wanders, R.J.10
-
5
-
-
0038460064
-
The chemical biology of branched-chain lipid metabolism
-
M. Mukherji, C.J. Schofield, A.S. Wierzbicki, G.A. Jansen, R.J. Wanders, and M.D. Lloyd The chemical biology of branched-chain lipid metabolism Prog. Lipid Res. 42 2003 359 376
-
(2003)
Prog. Lipid Res.
, vol.42
, pp. 359-376
-
-
Mukherji, M.1
Schofield, C.J.2
Wierzbicki, A.S.3
Jansen, G.A.4
Wanders, R.J.5
Lloyd, M.D.6
-
6
-
-
0034956080
-
Peroxisomal fatty acid alpha- and beta-oxidation in humans: Enzymology, peroxisomal metabolite transporters and peroxisomal diseases
-
R.J. Wanders, P. Vreken, S. Ferdinandusse, G.A. Jansen, H.R. Waterham, C.W. van Roermund, and E.G. Van Grunsven Peroxisomal fatty acid alpha- and beta-oxidation in humans: enzymology, peroxisomal metabolite transporters and peroxisomal diseases Biochem. Soc. Trans. 29 2001 250 267
-
(2001)
Biochem. Soc. Trans.
, vol.29
, pp. 250-267
-
-
Wanders, R.J.1
Vreken, P.2
Ferdinandusse, S.3
Jansen, G.A.4
Waterham, H.R.5
Van Roermund, C.W.6
Van Grunsven, E.G.7
-
7
-
-
0036316242
-
Refsum's disease: A peroxisomal disorder affecting phytanic acid alpha-oxidation
-
A.S. Wierzbicki, M.D. Lloyd, C.J. Schofield, M.D. Feher, and F.B. Gibberd Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation J. Neurochem. 80 2002 727 735
-
(2002)
J. Neurochem.
, vol.80
, pp. 727-735
-
-
Wierzbicki, A.S.1
Lloyd, M.D.2
Schofield, C.J.3
Feher, M.D.4
Gibberd, F.B.5
-
10
-
-
0034877163
-
Cytochrome P450 4A fatty acid omega hydroxylases
-
R.T. Okita, and J.R. Okita Cytochrome P450 4A fatty acid omega hydroxylases Curr. Drug Metab. 2 2001 265 281
-
(2001)
Curr. Drug Metab.
, vol.2
, pp. 265-281
-
-
Okita, R.T.1
Okita, J.R.2
-
11
-
-
0031049745
-
The cytochrome P450 4 (CYP4) family
-
A.E. Simpson The cytochrome P450 4 (CYP4) family Gen. Pharmacol. 28 1997 351 359
-
(1997)
Gen. Pharmacol.
, vol.28
, pp. 351-359
-
-
Simpson, A.E.1
-
13
-
-
0020663078
-
2,6-Dimethyloctanedioic-acid-a metabolite of phytanic acid in Refsum's disease
-
J. Greter, S. Lindstedt, and G. Steen 2,6-Dimethyloctanedioic-acid-a metabolite of phytanic acid in Refsum's disease Clin. Chem. 29 1983 434 437
-
(1983)
Clin. Chem.
, vol.29
, pp. 434-437
-
-
Greter, J.1
Lindstedt, S.2
Steen, G.3
-
14
-
-
0020033321
-
3-Methyladipate excretion in Refsum's disease
-
D.P. Brenton, and S. Krywawych 3-Methyladipate excretion in Refsum's disease Lancet 319 1982 624
-
(1982)
Lancet
, vol.319
, pp. 624
-
-
Brenton, D.P.1
Krywawych, S.2
-
15
-
-
0142010590
-
Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum disease
-
A.S. Wierzbicki, P.D. Mayne, M.D. Lloyd, D. Burston, G. Mei, M.C. Sidey, M.D. Feher, and F.B. Gibberd Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum disease J. Lipid Res. 44 2003 1481 1488
-
(2003)
J. Lipid Res.
, vol.44
, pp. 1481-1488
-
-
Wierzbicki, A.S.1
Mayne, P.D.2
Lloyd, M.D.3
Burston, D.4
Mei, G.5
Sidey, M.C.6
Feher, M.D.7
Gibberd, F.B.8
-
16
-
-
3042520951
-
Omega-hydroxylation of phytanic acid in rat liver microsomes: Implications for Refsum disease
-
J.C. Komen, M. Duran, and R.J. Wanders Omega-hydroxylation of phytanic acid in rat liver microsomes: implications for Refsum disease J. Lipid Res. 45 2004 1341 1346
-
(2004)
J. Lipid Res.
, vol.45
, pp. 1341-1346
-
-
Komen, J.C.1
Duran, M.2
Wanders, R.J.3
-
17
-
-
0033199499
-
P450 gene induction by structurally diverse xenochemicals: Central role of nuclear receptors CAR, PXR, and PPAR
-
D.J. Waxman P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR Arch. Biochem. Biophys. 369 1999 11 23
-
(1999)
Arch. Biochem. Biophys.
, vol.369
, pp. 11-23
-
-
Waxman, D.J.1
-
18
-
-
0034655747
-
Regulation of cytochrome P450 (CYP) genes by nuclear receptors
-
P. Honkakoski, and M. Negishi Regulation of cytochrome P450 (CYP) genes by nuclear receptors Biochem. J. 347 2000 321 337
-
(2000)
Biochem. J.
, vol.347
, pp. 321-337
-
-
Honkakoski, P.1
Negishi, M.2
-
19
-
-
20544473017
-
Regulation and inhibition of arachidonic acid -hydroxylases and 20-HETE formation
-
D.L. Kroetz, and F. Xu Regulation and inhibition of arachidonic acid -hydroxylases and 20-HETE formation Annu. Rev. Pharmacol. Toxicol. 2004
-
(2004)
Annu. Rev. Pharmacol. Toxicol.
-
-
Kroetz, D.L.1
Xu, F.2
-
21
-
-
0020559784
-
Effect of cyclodextrins on the solubilization of lignoceric acid, ceramide, and cerebroside, and on the enzymatic reactions involving these compounds
-
I. Singh, and Y. Kishimoto Effect of cyclodextrins on the solubilization of lignoceric acid, ceramide, and cerebroside, and on the enzymatic reactions involving these compounds J. Lipid Res. 24 1983 662 665
-
(1983)
J. Lipid Res.
, vol.24
, pp. 662-665
-
-
Singh, I.1
Kishimoto, Y.2
-
22
-
-
0036015842
-
Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid
-
M. Mukherji, N.J. Kershaw, C.J. Schofield, A.S. Wierzbicki, and M.D. Lloyd Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid Chem. Biol. 9 2002 597 605
-
(2002)
Chem. Biol.
, vol.9
, pp. 597-605
-
-
Mukherji, M.1
Kershaw, N.J.2
Schofield, C.J.3
Wierzbicki, A.S.4
Lloyd, M.D.5
-
23
-
-
3843053654
-
Liver fatty acid-binding protein gene ablation inhibits branched-chain fatty acid metabolism in cultured primary hepatocytes
-
B.P. Atshaves, A.M. McIntosh, O.I. Lyuksyutova, W. Zipfel, W.W. Webb, and F. Schroeder Liver fatty acid-binding protein gene ablation inhibits branched-chain fatty acid metabolism in cultured primary hepatocytes J. Biol. Chem. 279 2004 30954 30965
-
(2004)
J. Biol. Chem.
, vol.279
, pp. 30954-30965
-
-
Atshaves, B.P.1
McIntosh, A.M.2
Lyuksyutova, O.I.3
Zipfel, W.4
Webb, W.W.5
Schroeder, F.6
-
24
-
-
3242669109
-
Fatty acid-binding proteins-insights from genetic manipulations
-
N.H. Haunerland, and F. Spener Fatty acid-binding proteins-insights from genetic manipulations Prog. Lipid Res. 43 2004 328 349
-
(2004)
Prog. Lipid Res.
, vol.43
, pp. 328-349
-
-
Haunerland, N.H.1
Spener, F.2
-
25
-
-
0028989491
-
Structural basis of selective cytochrome P450 inhibition
-
J.R. Halpert Structural basis of selective cytochrome P450 inhibition Annu. Rev. Pharmacol. Toxicol. 35 1995 29 53
-
(1995)
Annu. Rev. Pharmacol. Toxicol.
, vol.35
, pp. 29-53
-
-
Halpert, J.R.1
-
26
-
-
0036176695
-
Inhibition of cytochromes P450 by antifungal imidazole derivatives
-
W. Zhang, Y. Ramamoorthy, T. Kilicarslan, H. Nolte, R.F. Tyndale, and E.M. Sellers Inhibition of cytochromes P450 by antifungal imidazole derivatives Drug Metab. Dispos. 30 2002 314 318
-
(2002)
Drug Metab. Dispos.
, vol.30
, pp. 314-318
-
-
Zhang, W.1
Ramamoorthy, Y.2
Kilicarslan, T.3
Nolte, H.4
Tyndale, R.F.5
Sellers, E.M.6
-
27
-
-
0026595179
-
Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture
-
M. Maurice, L. Pichard, M. Daujat, I. Fabre, H. Joyeux, J. Domergue, and P. Maurel Effects of imidazole derivatives on cytochromes P450 from human hepatocytes in primary culture FASEB J. 6 1992 752 758
-
(1992)
FASEB J.
, vol.6
, pp. 752-758
-
-
Maurice, M.1
Pichard, L.2
Daujat, M.3
Fabre, I.4
Joyeux, H.5
Domergue, J.6
Maurel, P.7
-
28
-
-
0032718355
-
Interspecies variations in fatty acid hydroxylations involving cytochromes P450 2E1 and 4A
-
F. Adas, F. Berthou, J.P. Salaun, Y. Dreano, and Y. Amet Interspecies variations in fatty acid hydroxylations involving cytochromes P450 2E1 and 4A Toxicol. Lett. 110 1999 43 55
-
(1999)
Toxicol. Lett.
, vol.110
, pp. 43-55
-
-
Adas, F.1
Berthou, F.2
Salaun, J.P.3
Dreano, Y.4
Amet, Y.5
|